Lmr Partners LLP Infinity Pharmaceuticals, Inc. Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $20,399 - $49,957	41,631 New	41,631 $26,000
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $81,212 - $105,942	-30,531 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $60,451 - $163,646	30,531 New	30,531 $99,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.